Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses

Modified vaccinia virus Ankara (MVA), an attenuated poxvirus, has been developed as a potential vaccine vector for use against cancer and multiple infectious diseases, including human immunodeficiency virus (HIV). MVA is highly immunogenic and elicits strong cellular and humoral responses in preclin...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Virol
Huvudupphovsmän: Chea, Lynette S., Wyatt, Linda S., Gangadhara, Sailaja, Moss, Bernard, Amara, Rama R.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2019
Ämnen:
Vaccines and Antiviral Agents
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6384055/
https://ncbi.nlm.nih.gov/pubmed/30541829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01648-18
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk